Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue

Issues

A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio

Valentina Paracchini1 / Paola Pedotti2 / Sara Raimondi3 / Seymour Garte4 / H. Leon Bradlow5 / Daniel W. Sepkovic6 / Emanuela Taioli7

1.

2.

3.

4.

5.

6.

7.

Corresponding author: Emanuela Taioli, MD PhD, Molecular and Genetic Epidemiology Unit, Fondazione Ospedale Policlinico IRCCS, Palazzina Bertarelli, Via Pace 9, 20122 Milano, Italy Phone/Fax: +39-02-55034055,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 43, Issue 7, Pages 702–706, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.119, July 2005

Publication History

Received:
April 19, 2005
Accepted:
April 25, 2005

Abstract

Cytochrome P450 (CYP) is a multigene family of enzymes involved in important life functions; some of these genes are inducible and are implicated in the oxidative metabolic activation and detoxification of many endogenous and exogenous compounds. CYP1B1 codes for an enzyme that catalyses the production of a 2- and 4-hydroxyl group in estrone and estradiol, while CYP1A1 catalyzes the 2-hydroxylation of estradiol in endometrium. The two genes were evaluated in a cohort of 150 subjects: African-American women had significantly lower 2-hydroxyl estrone/16-hydroxyl estrone (2-OHE1/16-OHE1) urinary metabolite ratios than Caucasian women (2.06±1.05 vs. 1.43±0.56; p=0.0002). A common polymorphism in the CYP1B1 gene (leucine to valineat codon 432) was associated with changes in urinary estrogen levels: both Caucasian and African-American women carrying the variant allele showed higher urinary metabolite ratios than women with the wild-type allele. No effect of the CYP1A1 MspI was observed. The 4-OHE1/2-OHE1 ratio was lower in subjects carrying the variant allele (Leu). The percentage change in 2-OHE1/16-OHE1 urinary ratio after indole treatment was significant in both Caucasian and African-American women carrying the wild-type CYP1B1 genotype, although it was more evident in African-Americans than in Caucasians. These results suggest that the Leu/Val CYP1B1 polymorphism may modify estradiol metabolism.

Keywords: chemoprevention; epidemiology; estrogen metabolism; transitional study

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Toshiro Niwa, Norie Murayama, Yurie Imagawa, and Hiroshi Yamazaki
Drug Metabolism Reviews, 2015, Volume 47, Number 2, Page 89
[2]
Muhammad Zahid, Cheryl L. Beseler, James B. Hall, Tricia LeVan, Ercole L. Cavalieri, and Eleanor G. Rogan
International Journal of Cancer, 2014, Volume 134, Number 10, Page 2414
[3]
Ni Li, Yong Zhou, Liang Du, Maoling Wei, and Xiaoming Chen
Experimental Eye Research, 2011, Volume 93, Number 5, Page 572
[4]
Ikuko Kato, Michelle Cichon, Cecilia L. Yee, Susan Land, and Jeannette F. Korczak
Cancer Epidemiology, 2009, Volume 33, Number 1, Page 24
[5]
A. Im, V. G. Vogel, G. Ahrendt, S. Lloyd, C. Ragin, S. Garte, and E. Taioli
Carcinogenesis, 2009, Volume 30, Number 9, Page 1532
[6]
Naoki Shimada, Motoki Iwasaki, Yoshio Kasuga, Shiro Yokoyama, Hiroshi Onuma, Hideki Nishimura, Ritsu Kusama, Gerson Shigeaki Hamada, Ines Nobuko Nishimoto, Hirofumi Iyeyasu, Juvenal Motola, Fábio Martins Laginha, Norie Kurahashi, and Shoichiro Tsugane
Journal of Human Genetics, 2009, Volume 54, Number 4, Page 209
[7]
Page E. Abrahamson, Shelley S. Tworoger, Erin J. Aiello, Leslie Bernstein, Cornelia M. Ulrich, Frank D. Gilliland, Frank Z. Stanczyk, Richard Baumgartner, Kathy Baumgartner, Bess Sorensen, Rachel Ballard-Barbash, and Anne McTiernan
Breast Cancer Research and Treatment, 2007, Volume 105, Number 1, Page 45
[8]
Heather Greenlee, Yu Chen, Geoffrey C. Kabat, Qiao Wang, Muhammad G. Kibriya, Irina Gurvich, Daniel W. Sepkovic, H. Leon Bradlow, Ruby T. Senie, Regina M. Santella, and Habibul Ahsan
Breast Cancer Research and Treatment, 2007, Volume 102, Number 1, Page 111

Comments (0)

Please log in or register to comment.